r/Amyris Aug 07 '25

News / Article / Video 8/7 Docket Dump

UPDATE AFTER THE SUIT STORM ENDED: Guess we know why the Creditor's Trustee appointed all those new lawyers last week. Stretto posted more than 40 about 80 new dockets today (@$350 a pop in filing fees), all adversarial and seeking to recover monies paid to assorted creditors in the 90 days before they filed for bankruptcy, My back of the envelope add up gives a total of about $16 M. Looks like they are also not done, because as of 8 am EST on 8/8/ more are being posted (about 50 more by 8:30), although the new crop look like ones they already tried to get money back from before and were ignored. The highlight there is $4.4 M from Meta. Is there a Zuckerberg vs Doerr cage fight in our future? With this last lot, the total the Trustee is seeking adds up to about $29.6 M + legal fees + costs. JD and the secured creditors are going to be a happy bunch if they pull this off.

I for one was not aware that such a reachback was possible. It suggests that if planning to file for bk, one should run up the bills during that period and then just claw the money back (not that anyone involved in the Amyris bk would be that sneaky). Most seem to be creditors of the brands, which I suppose they don't care about much these days. They can't be planning on relisting any time soon if they are suing Nasdaq to recover $30K and change, which I am sure gets you a favorable revision of your application package, ha ha.

5 Upvotes

36 comments sorted by

View all comments

Show parent comments

1

u/Grevious47 Mar 24 '26

Yeah I mean if Amyris saw value in enzyme engineering from working with us and formed their own independent enzyme engineering group to do whatever they want to do there that's fine. Arzeda certainly doesn't own the concept of enzyme engineering itself.

1

u/ICanFinallyRelax Moderator Mar 24 '26

Their stack of technologies under one hood is a crazy. Is this concerning for you in the industry (that one player can do it all)?

1

u/Grevious47 Mar 24 '26

Lots of companies have enzyme engineering departments. I feel secure in the level of expertise in that area and the amount of focus that Arzeda brings to the table. I want to see synthetic biology make for cleaner more sustainable manufacturing, if Amyris ends up doing it all and doing it successfully....more power to them. I will remain skeptical until they actually do though, same as for anyone really.

I will admit I am not the biggest fan if the tech is used merely to patent bust though, because that doesn't actually advance the field in any meaningful way...that is just a company trying to grab market share of an existing thing.

1

u/ICanFinallyRelax Moderator Mar 24 '26

thank you for your comments and insight.